Dabur Pharma enters into Sale & Distribution agreement with Hospira Inc

Dabur Pharma Ltd has announced that the sales and distribution agreement entered into between Dabur Oncology Plc, a Wholly Owned Subsidiary Company of the Company and Hospira Inc. for exclusive supply of oncology products for sales and distribution in the USA by Hospira Inc., has been terminated with mutual consent.

Going forward the Company will sell and distribute its entire range of oncology products in USA through its own infrastructure.

The stock closed on Friday at Rs.63.50, down by Rs..075 or 1.17%. The total traded quantity was 38106 compared to 2 week average of 24341. The stock hit an intraday high of Rs.64.90 and low of Rs.63.20.

Source : Equity Bulls

Keywords